![Reinhard Ambros](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Reinhard Ambros
Directeur/Membre du Conseil chez
REIN THERAPEUTICS INC.
Fortune : - $ au 30/06/2026
Profil
Reinhard J.
Ambros is currently Chairman at ImmunOs Therapeutics AG since 2026.
Holds director positions at Cylene Pharmaceuticals, Inc., Artidis AG, and Viridos, Inc. (since 2018).
Serves as Lead Independent Director at Rein Therapeutics, Inc. since 2018.
Former roles include Chairman at Genedata AG and Versameb AG.
Served as Director at Forma Therapeutics, Inc., Aerpio Therapeutics LLC, ESBATech (a Novartis Co. GmbH), Microchips Biotech, Inc., Symetis SA, and Novartis Bioventure Fund as Managing Director.
Was Independent Director at Tokai Pharmaceuticals, Inc. (2014) and Affluent Medical SA. Held positions at Novartis Corp.
and Novartis AG as Head of Strategic Planning (2001-2005), President of Novartis Venture Fund (2017), and Global Head of Business Development & Licensing at Novartis Pharma AG (2001-2005).
Education includes graduate and doctorate degrees from the University of Regensburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Reinhard Ambros
| Sociétés | Poste | Début |
|---|---|---|
| REIN THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/06/2013 |
Artidis AG
 Artidis AG Medical SpecialtiesHealth Technology Develops nano mechanical biomarker for rapid cancer diagnostics | Directeur/Membre du Conseil | - |
Viridos, Inc.
 Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes genomic-driven solutions and products | Directeur/Membre du Conseil | 25/06/2018 |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Directeur/Membre du Conseil | - |
ImmunOs Therapeutics AG
 ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins | Président | 01/01/2019 |
Anciens postes connus de Reinhard Ambros
| Sociétés | Poste | Fin |
|---|---|---|
Versameb AG
 Versameb AG Miscellaneous Commercial ServicesCommercial Services Operates as an preclinical-stage biopharmaceutical company | Président | 05/12/2023 |
Novartis Venture Funds
 Novartis Venture Funds Investment ManagersFinance NVF invests in companies located across North America and Europe. The firm focuses on biotechnology & biopharmaceutical and Life science sectors. It provides financing for early and later stage transactions with an investment size up to USD 30 million per company and also acts as lead or co-lead investor. The firm takes a seat on the board of directors. | Private Equity Investor | 31/08/2017 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Directeur/Membre du Conseil | 16/10/2014 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01/01/2005 |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Reinhard Ambros
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Viridos, Inc.
Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes genomic-driven solutions and products | Commercial Services |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Aerpio Therapeutics LLC
 Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Commercial Services |
Microchips Biotech, Inc.
 Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Health Technology |
Genedata AG
 Genedata AG Packaged SoftwareTechnology Services Provides software solutions for biopharmaceutical R&D | Technology Services |
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance NVF invests in companies located across North America and Europe. The firm focuses on biotechnology & biopharmaceutical and Life science sectors. It provides financing for early and later stage transactions with an investment size up to USD 30 million per company and also acts as lead or co-lead investor. The firm takes a seat on the board of directors. | Finance |
University of Regensburg
 University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symetis SA
 Symetis SA BiotechnologyHealth Technology Develops products for pediatric cardio-vascular applications | Health Technology |
Novartis Bioventure Fund
 Novartis Bioventure Fund Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Health Technology |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Affluent Medical SA
 Affluent Medical SA Medical SpecialtiesHealth Technology Develops and manufactures minimally invasive prostheses | Health Technology |
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins | Health Technology |
Artidis AG
Artidis AG Medical SpecialtiesHealth Technology Develops nano mechanical biomarker for rapid cancer diagnostics | Health Technology |
Versameb AG
Versameb AG Miscellaneous Commercial ServicesCommercial Services Operates as an preclinical-stage biopharmaceutical company | Commercial Services |
